Ledger.Open graph →
SEC Form D · filed November 25, 2025

Regenimo Biosciences, Inc

Offering
$2.0M
Sold
$2.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
HOUSTON, TX
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Lynda Chin · Houston, TXDirectorSharon Shacham · Newton, MAExec · DirectorRaju Kucherlapati · Cambridge, MADirectorSharon Shacham · Cambridge, MAExec · DirectorLynda Chin · Princeton, NJDirectorRaju Kucherlapati · Weston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗